Amylyx Pharmaceuticals Inc (AMLX) earnings · $561.6M cap
These earnings events as JSON? API free 100/dayAmylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
This AMLX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported AMLX revenue for 2025-12-31 was $0. Net income was -$144.7M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AMLX currently screens at market cap $561.6M.
When the next AMLX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 100.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full AMLX research stays on the stock page; the tape stays on the quote page.
AMLX earnings FAQ
What is AMLX's latest net income?
Latest cached Amylyx Pharmaceuticals Inc (AMLX) net income was -$144.7M. Statements: https://lician.com/financials/amlx
What is AMLX's latest diluted EPS?
Latest cached Amylyx Pharmaceuticals Inc (AMLX) diluted EPS for Dec 31, 2025 was -$1.53.
What period does the latest AMLX earnings print cover?
The latest cached Amylyx Pharmaceuticals Inc (AMLX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
Where are AMLX earnings listed?
Cached earnings facts for Amylyx Pharmaceuticals Inc (AMLX) are listed at https://lician.com/earnings/amlx. Statements: https://lician.com/financials/amlx
Not investment advice.